Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The nicotine inhaler is a prescription smoking cessation aid consisting of a mouthpiece and a plastic cartridge that delivers 4 mg of nicotine from a porous plug containing 10 mg nicotine. Unlike cigarettes or asthma inhalers, the nicotine is absorbed primarily in the mouth and throat rather than the lungs. Users take frequent, short puffs over about 20 minutes per cartridge. The inhaler helps reduce nicotine withdrawal symptoms and cigarette cravings by providing controlled nicotine delivery without the harmful chemicals found in cigarette smoke. It's recommended for use as part of a comprehensive behavioral smoking cessation program.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nicotine inhaler.